GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Net Income (Continuing Operations)

Techno Drugs (DHA:TECHNODRUG) Net Income (Continuing Operations) : BDT142 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Techno Drugs's Net Income (Continuing Operations) for the three months ended in Dec. 2024 was BDT63 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was BDT142 Mil.

Techno Drugs Net Income (Continuing Operations) Historical Data

The historical data trend for Techno Drugs's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Net Income (Continuing Operations) Chart

Techno Drugs Annual Data
Trend
Net Income (Continuing Operations)

Techno Drugs Quarterly Data
Sep23 Dec23 Sep24 Dec24
Net Income (Continuing Operations) 103.09 100.38 78.11 63.50

Techno Drugs Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Drugs  (DHA:TECHNODRUG) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Techno Drugs Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Techno Drugs's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Techno Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Net Income (Continuing Operations)
Comparable Companies
DHA:ASIATICLAB DHA:CENTRALPHL DHA:ORIONINFU DHA:ACMELAB ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM
Traded in Other Exchanges
N/A
Address
31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Website
https://www.technodrugsltd.com
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines